SE433493B - Analogiforfarande for framstellning av basiskt substituerade 0-propylerade oximer eller fysiologiskt godtagbara syraadditionssalter derav - Google Patents

Analogiforfarande for framstellning av basiskt substituerade 0-propylerade oximer eller fysiologiskt godtagbara syraadditionssalter derav

Info

Publication number
SE433493B
SE433493B SE7714684A SE7714684A SE433493B SE 433493 B SE433493 B SE 433493B SE 7714684 A SE7714684 A SE 7714684A SE 7714684 A SE7714684 A SE 7714684A SE 433493 B SE433493 B SE 433493B
Authority
SE
Sweden
Prior art keywords
formula
compounds
group
carbon atoms
addition salts
Prior art date
Application number
SE7714684A
Other languages
English (en)
Swedish (sv)
Other versions
SE7714684L (sv
Inventor
U Gebert
E Granzer
H-G Greve
W Thorwart
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7714684L publication Critical patent/SE7714684L/xx
Publication of SE433493B publication Critical patent/SE433493B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Epoxy Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7714684A 1976-12-24 1977-12-22 Analogiforfarande for framstellning av basiskt substituerade 0-propylerade oximer eller fysiologiskt godtagbara syraadditionssalter derav SE433493B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762658762 DE2658762A1 (de) 1976-12-24 1976-12-24 Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
SE7714684L SE7714684L (sv) 1978-06-25
SE433493B true SE433493B (sv) 1984-05-28

Family

ID=5996577

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714684A SE433493B (sv) 1976-12-24 1977-12-22 Analogiforfarande for framstellning av basiskt substituerade 0-propylerade oximer eller fysiologiskt godtagbara syraadditionssalter derav

Country Status (18)

Country Link
US (1) US4358450A (de)
JP (2) JPS6044307B2 (de)
AT (1) AT359069B (de)
AU (1) AU514855B2 (de)
BE (1) BE862302A (de)
CA (1) CA1105019A (de)
CH (2) CH639654A5 (de)
DE (1) DE2658762A1 (de)
DK (1) DK146886C (de)
ES (3) ES465203A1 (de)
FI (1) FI773902A (de)
FR (1) FR2375224A1 (de)
GB (1) GB1542793A (de)
GR (1) GR71598B (de)
IT (1) IT1088927B (de)
NL (1) NL7714057A (de)
SE (1) SE433493B (de)
ZA (1) ZA777584B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
US5214054A (en) * 1988-05-18 1993-05-25 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
US5229404A (en) * 1988-05-18 1993-07-20 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
JP2765876B2 (ja) * 1988-10-24 1998-06-18 科研製薬株式会社 ピリジルケトオキシムエーテル誘導体
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6089056A (en) * 1997-06-25 2000-07-18 Mitsui Kinzoku Kogyo Kabushiki Kaisha Structure for mounting a metallic pin into a resin part

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060177A (en) * 1957-11-11 1962-10-23 Ciba Geigy Corp O-(aminoalkyl)oxime derivatives of heterocyclic aldehydes and ketones
GB842968A (en) * 1957-11-11 1960-08-04 Ciba Ltd New o-aminoalkyl oximes
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes
GB1192995A (en) * 1967-04-12 1970-05-28 Egyt Gyogyszervegyeszeti Gyar Formimino Ethers
FR2187311B1 (de) * 1972-06-02 1975-06-20 Bouchara Emile
DE2235597A1 (de) * 1972-07-20 1974-01-31 Boehringer Mannheim Gmbh 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung
US4000274A (en) * 1972-12-23 1976-12-28 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an n-aryl-n'-(phenyl-or-phenoxy-alkyl)-piperazine and method of use
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
US4083978A (en) * 1976-01-27 1978-04-11 Egyt Gyogyszervegyeszeti Gyar Oxime ethers

Also Published As

Publication number Publication date
US4358450A (en) 1982-11-09
ATA924577A (de) 1980-03-15
FR2375224B1 (de) 1982-04-02
JPS54135774A (en) 1979-10-22
AT359069B (de) 1980-10-27
JPS53111076A (en) 1978-09-28
BE862302A (fr) 1978-06-23
ES468939A1 (es) 1978-12-16
CH639649A5 (de) 1983-11-30
GR71598B (de) 1983-06-17
SE7714684L (sv) 1978-06-25
CH639654A5 (de) 1983-11-30
CA1105019A (en) 1981-07-14
DE2658762A1 (de) 1978-06-29
GB1542793A (en) 1979-03-28
DK146886C (da) 1984-07-09
IT1088927B (it) 1985-06-10
NL7714057A (nl) 1978-06-27
DK575077A (da) 1978-06-25
AU3181477A (en) 1979-06-28
DK146886B (da) 1984-01-30
ES465203A1 (es) 1978-09-16
JPS6044307B2 (ja) 1985-10-02
ES468940A1 (es) 1978-12-16
AU514855B2 (en) 1981-03-05
JPS5910661B2 (ja) 1984-03-10
ZA777584B (en) 1978-11-29
FR2375224A1 (fr) 1978-07-21
FI773902A (fi) 1978-06-25

Similar Documents

Publication Publication Date Title
IL167316A (en) A method for the industrial synthesis of strontium as an analyte and its hydrates
SE456910B (sv) 7-substituerad teofyllin, saett att framstaella denna och en farmaceutisk komposition
SE465220B (sv) Piperazinsubstituerade estrar och amider av dihydropyridindikarboxylsyror, saett att framstaella dessa och en farmaceutisk komposition
EP0007019A1 (de) Neue 5-Phenylpyrazol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
SE433493B (sv) Analogiforfarande for framstellning av basiskt substituerade 0-propylerade oximer eller fysiologiskt godtagbara syraadditionssalter derav
US4404384A (en) O-[3-(4-Substituted-piperazin-1-yl)-2-hydroxypropyl]-hydroxylamines
McManus et al. Sulfamylurea hypoglycemic agents. I. Synthesis and screening
US3862955A (en) Process for the preparation of 1,2-benzisothiazolin 3-ones
US4619929A (en) Phenylpiperazine derivatives of hetarylphenols and hetarylanilines, their preparation, and therapeutic agents containing these compounds
HU197881B (en) Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
NO165104B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
US3706755A (en) Certain 4(3-(4-(phenyl)-3,6-dihydro-1(2h)pyridyl)-2 - hydroxy-propoxy)-benzophenones
IE50665B1 (en) Immunoregulatory pyridines and pyrimidines
US3699116A (en) 2,2'-azines of 2,4-thiazolidinediones
US4469686A (en) Substituted phosphinic acids
EP0095450A2 (de) Verfahren zur Herstellung von therapeutisch wirksamen Dihydropyridinen und Zwischenprodukte für diese Verfahren
US3965112A (en) Imidazoline derivatives
US4328227A (en) Novel O-propyloximes
Bosc et al. New investigation of the reaction of 2-amino-2-oxazolines with isocyanates and isothiocyanates. Evidence of a transposition during the second step
US3308024A (en) Method of tranquilization
DE2811638A1 (de) Substituierte aryloxy-aminopropanole und verfahren zu deren herstellung
US4207317A (en) 1-Aryl-4-carbamoyl-pyrazolin-5-ones
US3812129A (en) Piperazinyl substituted alkoxy benzophenones
SE435507B (sv) Forfarande for framstellning av trimetoxifenoxi-propyl-piperezinderivat
US4156735A (en) Thiazolidine derivatives